OPEN END TURBO OPTIONSSCHEIN LONG - QUEST DIAGNOSTICS | Real-time Bid/Ask 18:34:48 04/06/2024 BST | ||
| 0.87 EUR / 0.92 EUR | +11.87% |
|
| Current month | +9.59% | ||
| 1 month | +50.94% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 04/06/24 | 0.78 | -2.50% |
| 03/06/24 | 0.8 | +9.59% |
| 31/05/24 | 0.73 | +10.61% |
| 30/05/24 | 0.66 | +15.79% |
| 29/05/24 | 0.57 | -13.64% |
Delayed Quote Börse Stuttgart
Last update June 04, 2024 at 04:52 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GG71B2 |
| ISIN | DE000GG71B25 |
| Date issued | 25/04/2024 |
| Strike | 133.1 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.57 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.2 € |
|---|---|
| Lowest since issue | 0.33 € |
| Spread | 0.05 € |
| Spread % | 5.68% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
141.1
USD
Average target price
147
USD
Spread / Average Target
+4.17%
- Stock Market
- Certificates
- Certificat
